Covaxin gets approval for Emergency Use. Restricted Emergency use for Covaxin. Approval for India’s first Indigenous Vaccine.
Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.
Expert panel recommends granting permission for restricted emergency use authorisation for Bharat Biotech’s indigenously developed COVID-19 vaccine.ANI
An expert panel of India’s central drug authority on Saturday recommended granting permission for restricted emergency use of the indigenously developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar direction for the Oxford COVID-19 vaccine, sources said.
Bharat Biotech had applied to the Drugs Controller General Of India seeking emergency use authorisation for its Covaxin on December 7.
On Friday, the SEC had recommended granting permission for restricted emergency use of Oxford-AstraZeneca vaccine Covishield, manufactured by the Serum Institute of India.
